In 2019, Tobinco initiated legal action against the FDA, arguing that the agency's actions were unlawful and seeking damages. Tobinco's legal representation was led by Mr Philip Addison of Addison Bright Sloane, a law firm based in Accra. The case was presided over by Justice Audrey Kocuvie-Tay, who ruled on 29 July 2024 that the FDA's destruction of Tobinco's unexpired products was illegal as it had not obtained a court order to justify its actions. The court further stated that the FDA's subsequent actions, including locking up Tobinco's warehouses and generating negative media coverage, led to significant losses for the company due to the expiration of products between June 2014 and August 2015. Justice Kocuvie-Tay also criticised the FDA for banning Bliss GVS Pharma Limited from importing drugs into Ghana without the required Executive Instrument from the Minister of Health.